Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/8/25 16:35 | 9/9/25 | SERA | Health | Health | Medical Laboratories | Harrison Robert Gardner | UT | O | CIO | 5 | S | -43 | 2.59 | 0 | -17 | 109 | D | |||||||||||||||
10/6/25 16:15 | 9/5/25 | SERA | Health | Health | Medical Laboratories | Mirza Mansoor Raza | UT | D | 3 | S | -2 | 3.00 | 0 | -1 | 59 | D | ||||||||||||||||
9/12/25 16:36 | 9/9/25 | SERA | Health | Health | Medical Laboratories | Lindgardt Zhenya | UT | DO | CEO | 3 | S | -99 | 2.99 | 0 | -33 | 832 | D | |||||||||||||||
9/12/25 16:36 | 9/2/25 | SERA | Health | Health | Medical Laboratories | Kearney Paul | UT | O | Chief Da | 4 | S | -62 | 3.16 | 0 | -20 | 189 | D | |||||||||||||||
9/12/25 16:35 | 8/8/25 | SERA | Health | Health | Medical Laboratories | Jackson Benjamin | UT | O | GC | 2 | S | -19 | 2.61 | 0 | -7 | 128 | D | |||||||||||||||
9/12/25 16:35 | 8/8/25 | SERA | Health | Health | Medical Laboratories | Boniface John J. | UT | O | Chief Sc | 2 | S | -22 | 2.64 | 0 | -8 | 161 | D | |||||||||||||||
9/12/25 16:34 | 9/9/25 | SERA | Health | Health | Medical Laboratories | Aerts Austin | UT | O | CFO | 3 | S | -34 | 2.85 | 0 | -12 | 291 | D | |||||||||||||||
9/11/25 16:59 | 9/9/25 | SERA | Health | Health | Medical Laboratories | Lawrence Sandra Aj | UT | D | 2 | S | -17 | 3.05 | 0 | -5 | 21 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |